InvestorsHub Logo
icon url

capnmike

04/12/08 4:30 PM

#25724 RE: capnmike #25723

CDEX, James Stevenson, Cleveland Clinic, John F Mitchell, and so on and so on.

Interesting.

Am J Health Syst Pharm. 2007 May 1;64 (9):955-9 17468151 (P,S,E,B,D) Medication errors in inpatient pharmacy operations and technologies for improvement.

[My paper] Seth Alan Kuiper, Scott R McCreadie, John F Mitchell, James G Stevenson
The Cleveland Clinic Foundation, Cleveland, OH.

http://lib.bioinfo.pl/pmid:17468151

Improving Medication Safety: Independent 18 Month Study of ValiMed™ Medication Validation System by CDEX Published in American Journal of Health-System Pharmacists
ValiMed™ detected five potentially serious medication errors while consistently validating the correct medication solutions during an 18 month study at a major University Hospital.

Tucson, Arizona – January 7, 2008 – CDEX Inc. (OTCBB: CEXI) announces publication of an 18 month independent study of the ValiMed™ Medication Validation System at the C.S. Mott Children's Hospital in the University of Michigan Health System in the American Journal of Health-System Pharmacists. “During the 18 months since [ValiMed] was implemented, five potentially serious medication errors have been detected and avoided,” the report stated. “[ValiMed] consistently validated the correct solution, while dependably detecting as invalid the wrong drug or concentrations that departed substantially from the targeted standard.” (Am J Health-Syst Pharm--Vol 65, pp 49-54, Jan 1, 2008, "Enhanced Photoemission Spectroscopy for Verification of High-Risk IV Medications”).

"Errors in compounding these types of medications are rare. However, when they occur they can have a significant negative impact on patients and staff," said one of the authors, Jim Stevenson, Associate Dean of Clinical Sciences at the University of Michigan College of Pharmacy and Director of Pharmacy Services at the University’s Health System. "Our goal is to have zero tolerance for errors. We know from having ValiMed™ in place we've deterred five potentially serious errors that might have happened. I really believe having technology like this needs to be the standard around the country." (Stevenson's statements are drawn from a University of Michigan press release and are quoted with permission (see http://www.ns.umich.edu/htdocs/releases/story.php?id=6255.)

“This peer reviewed Study was a comprehensive analysis of our patented technologies and first generation ValiMed units,” said Malcolm Philips, CDEX CEO. “Jim Stevenson and his Staff at the University of Michigan Health System are among the best and most forward thinking heath care organizations in the nation, with a zero tolerance policy for medication errors. They have stepped forward to tackle a significant problem facing the entire medical community and we look forward to working with them and other top rated national and international hospitals in our collective efforts to provide the best standard of care for patients.”

ValiMed™ uses Enhanced Photoemission Spectroscopy to quickly validate high-risk medication admixtures, as well as returned narcotics, to provide an increased level of patient safety. ValiMed compares a medication’s spectroscopic signature to its expected CDEX Library signature and returns an easy to understand “validated” or “not validated” result, requiring no user interpretation.

http://www.ns.umich.edu/htdocs/releases/story.php?id=6255

http://www.ns.umich.edu/htdocs/releases/print.php?htdocs/releases/plainstory.php?id=6255&html=

http://www.cdex-inc.com/pr/10708.html

CDEX to Demonstrate Validation of Flu Vaccine and Flu Medications at The American Society of Health Systems Pharmacists (ASHP) MidYear Clinical Meeting December 4-8

Rockville, MD – November 14, 2005 – CDEX Inc. (OTCBB: CEXI), developer of the ValiMed™ Medication Validation System and other innovative substance detection and verification systems, announces its participation in the 40th MidYear Clinical Meeting of the American Society of Health Systems Pharmacists (ASHP) December 4-8, 2005 in Las Vegas. At ASHP, CDEX will be demonstrating its ValiMed Medication Validation System, and demonstrating how CDEX technology can be utilized to validate authentic influenza vaccine and Tamiflu medication. Counterfeiting of influenza remedies and many other medications and vaccines is a growing problem.

Poster: Monday, 12/5/2005, 2:00 p.m. Board 135, Improving medication safety: use of spectral medication validation in high risk intravenous medication (IV) compounding in a pediatric hospital pharmacy, Hanna Phan, Deborah Pasko, John F Mitchell, Denise K. Glenn, Diane S. Shoemaker, James G. Stevenson

http://www.cdex-inc.com/pr/111405.html


http://www.glprc.com/Abstracts/rptAbstracts%202007.pdf

John F. Mitchell, Medication Safety Coordinator, University of Michigan Hospitals and Health Centers and ISMP.

http://www.ismp.org/Tools/default.asp

Medication errors in inpatient pharmacy operations and technologies for improvement
Seth Alan Kuiper, Scott R. McCreadie, John F. Mitchell, and James G. Stevenson
Am J Health Syst Pharm 2007 64: 955-959. [Full Text] [PDF]

http://www.ajhp.org/content/vol64/issue9/index.dtl

http://www.ncbi.nlm.nih.gov/pubmed/17468151?dopt=AbstractPlus

http://www.omnicell.com/news_events/release_display.asp?page=98

American Journal of Health-System Pharmacy - Fulltext: Volume 64(9 ...JOHN F. MITCHELL, PHARM.D., is Medication Safety Coordinator, UMHHC. ..... pharmacy solutions. www.omnicell.com/PDF/solutions/Central_Pharmacy_Solutions.pdf ...
pt.wkhealth.com/pt/re/ajhp/fulltext.00043627-200705010-00020.htm

http://www.pharm.med.umich.edu/public/2006_annual_report/welcome.htm

http://www.zoominfo.com/Search/PersonDetail.aspx?PersonID=8266802

Smart Infusion Pumps: "Strategies for Selection and Implementation”-Part II

In Part II, John Mitchell from the University of Michigan, will provide help from the perspective of a health system that has successfully employed smart infusion pump technology. Citing first-hand experience, John will describe some challenges his organization faced, how medication libraries were developed and implemented for these infusion devices. Mark Sullivan from Vanderbilt University will lead a further discussion on the management of data collection that is generated from smart pumps as well as how this information can be used to reduce the risk of infusion therapy. A thirty-minute question and answer period will be provided for participants’ questions.

Please join ISMP for a two-part teleconference entitled, "Smart Infusion Pumps: Strategies for Selecting, Implementing and Identifying Risk” Part I will be held on June 6, 2007 from 1:30 to 3:00 PM ET and Part II will be held on June 21, 2007 from 1:30 to 3:00 PM ET.

INTENDED AUDIENCE (Interdisciplinary teams are encouraged to attend together):

http://www.ismp.org/teleconferences/default.asp?teleconferenceID=26

Hospitals with Contracts for Purchase or Lease of one or more CDEX ValiMed™ Medication Validation Systems

All Children’s Hospital, Inc. (St. Petersburg, Florida)
Children’s Hospitals and Clinics of Minnesota (Minneapolis, Minnesota)
Children’s Hospitals and Clinics of Minnesota (St. Paul, Minnesota)
Children’s Medical Center of Dallas (Dallas Texas)
Cleveland Clinic Foundation (Cleveland, Ohio)
Henry Ford Health System (Detroit, Michigan)
Loyola University Medical Center (Maywood, Illinois)
Mount Carmel Health System (Columbus, Ohio)
Primary Children’s Medical Center (Salt Lake City, Utah)
Stanford Hospitals and Clinics (Stanford, California)
U.C. Davis Health System (Sacramento, California)
University of Maryland Medical Center (Baltimore, Maryland)
University of Michigan Health System (Ann Arbor, Michigan)
University of Utah Hospitals and Clinics (Salt Lake City, Utah)
Veterans Administration Hospital (Palo Alto, California)
Children's Hospital of The King's Daughters (Norfolk, VA)
Bronson Methodist Hospital (Kalamazoo, MI)
East Jefferson General Hospital (Metairie, LA)

http://www.valimed.com/clients.htm